Please login to the form below

companion diagnostic

This page shows the latest companion diagnostic news and features for those working in and with pharma, biotech and healthcare.

Loxo, Bayer get quick FDA review for ‘precision’ cancer drug

To try to address that issue, Loxo formed a partnership earlier this year with Illumina to develop a companion diagnostic – called TruSight Tumour 170 – that will use sequencing to identify whether

Latest news

EMA starts firming up its stance on personalised medicines

New draft European guidelines on personalised medicines and companion diagnostics are expected to be released by December 2018. ... As diagnostic medical devices, companion diagnostics do not fall within the oversight of the EMA, but the regulator is set
Celgene, Agios get FDA OK for leukaemia drug Idhifa

A companion diagnostic from Abbott Labs that detects mutations in the IDH2 gene in blood or bone marrow samples has been approved alongside the new drug.
AZ takes Chi-Med’s kidney cancer drug into phase III

He noted that the company has developed a companion diagnostic that will be used to select patients for its phase III programme.
AZ gets first OK for PD-L1 inhibitor durvalumab

The FDA also approved Roche's Ventana PD-L1 assay as a companion diagnostic for assessing PD-L1 protein levels in biopsy tissue.
Novartis' Rydapt approval ends long AML therapy drought

The US agency cleared Novartis' Rydapt (midostaurin) for use alongside chemotherapy in newly-diagnosed AML patients who carry the FLT3 mutation, also giving the okay for a FLT3 companion diagnostic developed

More from news
Approximately 1 fully matching, plus 66 partially matching documents found.

Latest Intelligence

Harnessing complexity

This delicate balance between companion diagnostics' clinical utility and their potential confounding impact on patient treatment is a growing dilemma. ... Answering this question in full requires a scientific journey to better understand what a
Diagnostics are rising up the pharma value chain

Diagnostic drivers. It's not just this idea of changing public attitudes that is creating renewed interest in the diagnostics sector; the sector is also influenced by the wider forces affecting ... GlaxoSmithKline and Boehringer Ingelheim have had
Deal Watch table for June 2014

50. NanoString Technologies/ Celgene. Development. Development of a companion diagnostic assay.
Pharma deals during June 2014

a deal with NanoString Technologies for the development of a companion diagnostic assay to support the development of Revlimid for treatment of Diffuse Large B-Cell Lymphoma at a more modest
Interview: John Dineen, GE Healthcare

some of these markers can be converted into a companion diagnostic product after the completion of a late-stage clinical trial. ... We can then ensure our diagnostic is closely coupled with the therapeutic capability.

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

Companion Diagnostics Market Global Trends, Analysis and Forecast 2026

Major impact of companion diagnostic will been on oncology therapy area. ... Request Sample Report @ . Companion Diagnostics Market: Segmentation. Companion diagnostic global market is segmented into following segments:.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

New Business Director - PR: Competitive Salary and benefits

Account Manager – Creative Healthcare Advertising – Central Lond...: Salary TBC

Account Manager / Senior Account Manager: 35, 000-40, 000

Account Director: Excellent benefits

Account Manager, Healthcare Public Affairs: £32, 000 – £40, 000 benefits

Production Manager – Healthcare Communications: DOE

Associate Editorial Director – Med Comms – London: Salary TBC

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Medical Writers Required – Cheshire: DOE

Senior Medical Writer (Remote Working): Competitive Salary Offered

Programme Director, Healthcare PR, Highly competitive package: Highly Competitive package

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

Project / Account Manager (Medical Education): Salary TBC

Account Director - Healthcare Advertising - London - HOME WORKIN...: £50000 - £68000

Director, Market Access / HEOR - North-West: Negotiable

Senior Medical Writer: Competitive Salary

Client Services Director – Medical Education Agency – North West...: Salary TBC

Senior Account Managers - Oxfordshire: Attractive salary and benefits package offered

Senior Medical Writer: Great salary and benefits

Senior Systematic Review Analyst - Oxford: Negotiable

Digital Manager, London – Healthcare Brandcomms, Medcomms, PR: Excellent package

Freelance Account Manager / Senior Account Manager - Medical Edu...: £300 per day

Associate Director: £75, 000-90, 000

Consumer Health Account Director: Circa £60, 000 Gym and More

Account Director: £48, 000 - £60, 000

Subscribe to our email news alerts

PMHub

Add my company

Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...